Shiho Kurokawa
Chiba, 2608670, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Cationic Nanogel Coated Norovirus VLP Nasal Vaccine Induces Neutralizing Mucosal IgA and Serum IgG Antibodies.
Journal: Molecular pharmaceutics
Published: March 26, 2026
Zymosan-adjuvanted intranasal norovirus virus-like particle vaccine induces antiviral mucosal immune responses in infant mice.
Journal: Mucosal immunology
Published: December 08, 2025
H and B Blood Antigens Are Essential for In Vitro Replication of GII.2 Human Norovirus.
Journal: Open forum infectious diseases
Published: June 27, 2024
MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system.
Journal: Frontiers in plant science
Published: November 22, 2023
Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents.
Journal: NPJ vaccines
Published: January 21, 2023
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection.
Journal: Pharmaceutics
Published: November 16, 2022
Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
Journal: Vaccine
Published: November 09, 2021
Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery System.
Journal: Molecular pharmaceutics
Published: February 23, 2021
Development of Antibody-Fragment-Producing Rice for Neutralization of Human Norovirus.
Journal: Frontiers in plant science
Published: December 10, 2020
Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine.
Journal: BMC genomics
Published: April 29, 2020
Last Updated: 09/26/2026